Comments to FDA: PDUFA Share page: Docket Number: FDA-2010-N-0128 CHPA comments on proposed recommendations for the reauthorization of the Prescription Drug User Fee Act. Download Document Issues: OTC Medicines Monograph Reform Rx-to-OTC Switch User Fees Related Posts Comments Comments Regarding FDA Annual Reportable Labeling Changes for New Drug Applications and Abbreviated New Drug Applications for Nonprescription Drug Products May 13, 2024 Press Releases and Statements CHPA Applauds Vermont for Passing Sun Safety Bill Empowering Students to Better Protect their Skin May 8, 2024 Press Releases and Statements Tennessee Expands Access to OTC Cold & Allergy Medications Containing PSE May 7, 2024